EIV 4mL

Equinate IV 4mL (12 x 4mL)

Prescription Product

This is a Schedule 4 (S4) Controlled Substance. Supply is strictly regulated under Australian law. Valid authorisation is required to purchase this product.

Enquire today to create an account

Register
For treatment of lameness associated with non-infectious synovitis and degenerative joint disease

Indications: Equinate I.V. is indicated in the intravenous treatment of lameness in horses due to non-infectious synovitis possibly associated with early equine degenerative joint disease.

Active Constituents: Sodium Hyaluronate 10 mg/mL

Pack Size: 12 x 4mL Single Dose Vials
[Zebravet_Files]:
[Zebravet_Files]
Classification:
S4
Categorisation:
Prescription
Ingredients:
Sodium Hyaluronate 10mg/mL for IV use